Nov-209

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameNov-209
Drug Alias Namelantibiotic-based protein (Novacta)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovacta Biosystems Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovacta Biosystems Ltd
Active IndicationsN/A
Inactive IndicationsAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A